Impairing hydrolase transport machinery prevents human melanoma metastasis

Alice Nordlinger1, Justine Del Rio1, Shivang Parikh2

  • 1INSERM 1279, Tumor Cell Dynamics, Gustave Roussy, Université Paris-Saclay, Villejuif, France.

PubMed

Insights

Blocking hydrolase transport to lysosomes reduces melanoma cell spread. This triggers a compensatory pathway involving TFEB, which, when inhibited, restores invasiveness, suggesting new anti-metastasis therapies.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Metastasis is a leading cause of cancer mortality.
  • Molecular targets to inhibit cancer cell spread are largely unknown.

Purpose of the Study:

  • To investigate the role of hydrolase transport to lysosomes in melanoma invasiveness.
  • To identify molecular mechanisms regulating melanoma cell spread.

Main Methods:

  • Inhibition of IGF2R or GNPT to block hydrolase transport.
  • Analysis of lysosome biogenesis and TFEB expression.
  • Assessment of melanoma cell invasiveness.

Main Results:

  • Blocking hydrolase transport via IGF2R or GNPT significantly reduced melanoma invasiveness.
  • This blockage induced compensatory lysosome biogenesis lacking degradative enzymes.
  • Inhibition of TFEB restored melanoma invasiveness, highlighting its role in this regulatory loop.

Conclusions:

  • Targeting hydrolase transport to lysosomes is a potential therapeutic strategy to prevent melanoma metastasis.
  • Stimulating TFEB expression via inhibiting hydrolase transport may offer a novel approach for anti-metastasis therapies.